Teleflex Incorporated (TFX)
TFX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/0000096943-26-000019-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | TFX on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000096943 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.0B |
| Net income | -$905.6M |
| Operating income | $118.4M |
| Net margin | -45.4% |
| Operating margin | 5.9% |
| Revenue growth | +17.2% |
| Cash | $378.6M |
| Total assets | $6.9B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $430.5M cash; operating cash flow $80.3M a quarter. | Report 2026-09-30 |
| Shares outstanding | 39,661,261 (2026-11-03); 44,194,408 a year earlier; 46,992,664 three years earlier. | Cover page 2026-11-03 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Philadelphia, Pennsylvania, United States | PCAOB Form AP 2026-03-18 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $567.8M | $927.4M | $96.3M | $430.5M | $1.6B | $2.3B | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $570.3M | $99.7M | $91.9M | $300.2M | $2.8B | $2.3B | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $548.3M | -$8.2M | $46.7M | $309.4M | $2.6B | $2.1B | 10-Q 2026-05-07 |
| Q4 2025 2025-12-31 | $569.0M | -$714.3M | $86.4M | $378.6M | $2.6B | $2.0B | 10-K 2026-02-27 |
| Q3 2025 2025-09-28 | $566.9M | -$408.9M | $19.6M | $354.0M | $2.7B | $1.9B | 10-Q 2026-11-05 |
| Q2 2025 2025-06-29 | $442.5M | $122.6M | -$37.0M | $253.7M | $1.9B | $1.7B | 10-Q 2026-08-06 |
| Q1 2025 2025-03-30 | $414.3M | $95.0M | $27.7M | $284.1M | $1.9B | $1.7B | 10-Q 2026-05-07 |
| Q4 2024 2024-12-31 | $442.0M | -$136.7M | -$133.7M | $247.9M | $1.7B | $1.7B | 10-K 2026-02-27 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2017-11-17 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy | DEF 14A | 2026-04-13 |
Source: SEC EDGAR submissions feed, 1,008 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.8% |
| 1 month | +24.6% |
| 3 months | +12.9% |
| Year to date | +27.1% |
| 1 year | +41.7% |
| From 52-week high | -0.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HAE | Haemonetics Corporation | $121.34 | -1.30% | $5.5B |
| MMED | MiniMed Group Inc. | $18.65 | +3.67% | $5.2B |
| MMSI | Merit Medical Systems Inc. | $86.35 | -0.32% | $5.2B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| GMED | Globus Medical Inc. | $70.50 | -2.27% | $9.3B |
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier